PAX/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13)

Leukemia

Volumn 17, Issue 6, 2003, Pages 1121-1123

  Strehl, S ^a   Konig M ^a   Dworzak, M N ^a   Kalwak, K ^b   Haas, O A ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Childhood ALL; Dic(9; 12)(p13; p13); ETV6; PAX5; PAX5 ETV6 fusion transcript

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; LEUKOCYTE ANTIGEN; PAX5 PROTEIN, HUMAN; PRIMER DNA; REPRESSOR PROTEIN; RNA; TRANSCRIPTION FACTOR ETS;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CASE REPORT; CHROMOSOME 12P; CHROMOSOME 9P; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 9; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE LOCATION; GENE REARRANGEMENT; HUMAN; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; SCHOOL CHILD; B CELL LEUKEMIA; B LYMPHOCYTE; BLOOD; CHEMISTRY; CHILD; CHROMOSOME 12; CHROMOSOME 9; CHROMOSOME ABERRATION; GENE FUSION; GENE TRANSLOCATION; GENETICS; ISOLATION AND PURIFICATION; KARYOTYPING; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ANTIGENS, CD; ARTIFICIAL GENE FUSION; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 9; DNA PRIMERS; DNA-BINDING PROTEINS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0037702860     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402923     Document Type: Article

References (13)

1. Carroll AJ, Raimondi SC, Williams DL, Behm FG, Borowitz M, Castleberry RP et al. tdic(9;12): a nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Blood 1987; 70: 1962-1965.
2. Behrendt H, Charrin C, Gibbons B, Harrison CJ, Hawkins JM, Heerema NA et al. Dicentric (9;12) in acute lymphocytic leukemia and other hematological malignancies: report from a dic(9;12) study group. Leukemia 1995; 9: 102-106.
3. Mahmoud H, Carroll AJ, Behm F, Raimondi SC, Schuster J, Borowitz M et al. The non-random dic(9;12)translocation in acute lymphoblastic leukemia is associated with B-progenitor phenotype and an excellent prognosis. Leukemia 1992; 6: 703-707.
4. ISCN. Mitelman F (Ed.). An International System for Human Cytogenetic Nomenclature. Basel: Karger, 1995.
5. Busslinger M, Klix N, Pfeffer P, Graninger PG, Kozmik Z. Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. Proc Natl Acad Sci USA 1996; 93: 6129-6134.
6. Baens M, Peeters P, Guo C, Aerssens J, Marynen P. Genomic organization of TEL: the human ETS-variant gene 6. Genome Res 1996; 6: 404-413.
7. Cazzaniga G, Daniotti M, Tosi S, Giudici G, Aloisi A, Pogliani E et al. The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case. Cancer Res 2001; 61: 4666-4670.
8. Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P et al. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 1997; 90: 2535-2540.
9. Kuno Y, Abe A, Emi N, Iida M, Yokozawa T, Towatari M et al. Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12).). Blood 2001; 97: 1050-1055.
10. Andreasson P, Johansson B, Carlsson M, Jarlsfelt I, Fioretos T, Mitelman F et al. BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion. Genes Chromosomes Cancer 1997; 20: 299-304.
11. Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999; 401: 556-562.
12. Mikkola I, Heavey B, Horcher M, Busslinger M. Reversion of B cell commitment upon loss of Pax5 expression. Science 2002; 297: 110-113.
13. Nutt SL, Morrison AM, Dorfler P, Rolink A, Busslinger M. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J 1998; 17: 2319-2333.